These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 25544473

  • 1. Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.
    Chin M, De Zoysa M, Slinger R, Gaudet E, Vandemheen KL, Chan F, Hyde L, Mah TF, Ferris W, Mallick R, Aaron SD.
    J Cyst Fibros; 2015 Jul; 14(4):482-9. PubMed ID: 25544473
    [Abstract] [Full Text] [Related]

  • 2. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
    Lam JC, Somayaji R, Surette MG, Rabin HR, Parkins MD.
    BMC Infect Dis; 2015 Mar 22; 15():145. PubMed ID: 25887462
    [Abstract] [Full Text] [Related]

  • 3. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Tai AS, Sherrard LJ, Kidd TJ, Ramsay KA, Buckley C, Syrmis M, Grimwood K, Bell SC, Whiley DM.
    BMC Pulm Med; 2017 Nov 02; 17(1):138. PubMed ID: 29096618
    [Abstract] [Full Text] [Related]

  • 4. 2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent Pseudomonas aeruginosa burden in adults with cystic fibrosis.
    Zain NMM, Webb K, Stewart I, Halliday N, Barrett DA, Nash EF, Whitehouse JL, Honeybourne D, Smyth AR, Forrester DL, Knox AJ, Williams P, Fogarty A, Cámara M, Bruce KD, Barr HL.
    J Med Microbiol; 2021 Oct 02; 70(10):. PubMed ID: 34596013
    [Abstract] [Full Text] [Related]

  • 5. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
    Reid DW, Carroll V, O'May C, Champion A, Kirov SM.
    Eur Respir J; 2007 Aug 02; 30(2):286-92. PubMed ID: 17504792
    [Abstract] [Full Text] [Related]

  • 6. Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.
    Taylor RF, Hodson ME, Pitt TL.
    Thorax; 1993 Oct 02; 48(10):1002-5. PubMed ID: 8256228
    [Abstract] [Full Text] [Related]

  • 7. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
    Stressmann FA, Rogers GB, Marsh P, Lilley AK, Daniels TW, Carroll MP, Hoffman LR, Jones G, Allen CE, Patel N, Forbes B, Tuck A, Bruce KD.
    J Cyst Fibros; 2011 Sep 02; 10(5):357-65. PubMed ID: 21664196
    [Abstract] [Full Text] [Related]

  • 8. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
    Schiller NL, Millard RL.
    Pediatr Res; 1983 Sep 02; 17(9):747-52. PubMed ID: 6413945
    [Abstract] [Full Text] [Related]

  • 9. Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5-18-year-old cystic fibrosis patients.
    Billard-Pomares T, Herwegh S, Wizla-Derambure N, Turck D, Courcol R, Husson MO.
    J Med Microbiol; 2011 Feb 02; 60(Pt 2):157-161. PubMed ID: 20947668
    [Abstract] [Full Text] [Related]

  • 10. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
    Elborn JS, Cordon SM, Shale DJ.
    Pediatr Pulmonol; 1993 May 02; 15(5):287-91. PubMed ID: 8327287
    [Abstract] [Full Text] [Related]

  • 11. Nebulized tobramycin in the treatment of adult CF pulmonary exacerbations.
    Al-Aloul M, Nazareth D, Walshaw M.
    J Aerosol Med Pulm Drug Deliv; 2014 Aug 02; 27(4):299-305. PubMed ID: 24219814
    [Abstract] [Full Text] [Related]

  • 12. Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation.
    Huus KE, Joseph J, Zhang L, Wong A, Aaron SD, Mah TF, Sad S.
    J Immunol; 2016 Apr 01; 196(7):3097-108. PubMed ID: 26895832
    [Abstract] [Full Text] [Related]

  • 13. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
    Ohman DE, Chakrabarty AM.
    Infect Immun; 1982 Aug 01; 37(2):662-9. PubMed ID: 6811437
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary infection in cystic fibrosis.
    Friend PA.
    J Infect; 1986 Jul 01; 13(1):55-72. PubMed ID: 3090153
    [No Abstract] [Full Text] [Related]

  • 15. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Dunne WM, Chusid MJ.
    Diagn Microbiol Infect Dis; 1987 Feb 01; 6(2):165-70. PubMed ID: 3102157
    [Abstract] [Full Text] [Related]

  • 16. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study.
    Weiss B, Bujanover Y, Yahav Y, Vilozni D, Fireman E, Efrati O.
    Pediatr Pulmonol; 2010 Jun 01; 45(6):536-40. PubMed ID: 20503277
    [Abstract] [Full Text] [Related]

  • 17. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
    Gao YH, Guan WJ, Zhu YN, Chen RC, Zhang GJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr 12; 42(4):254-261. PubMed ID: 30955282
    [Abstract] [Full Text] [Related]

  • 18. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.
    Zemanick ET, Wagner BD, Harris JK, Wagener JS, Accurso FJ, Sagel SD.
    Pediatr Pulmonol; 2010 Jun 12; 45(6):569-77. PubMed ID: 20503282
    [Abstract] [Full Text] [Related]

  • 19. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients.
    Spilker T, Coenye T, Vandamme P, LiPuma JJ.
    J Clin Microbiol; 2004 May 12; 42(5):2074-9. PubMed ID: 15131172
    [Abstract] [Full Text] [Related]

  • 20. Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy.
    Bucher J, Boelle PY, Hubert D, Lebourgeois M, Stremler N, Durieu I, Bremont F, Deneuville E, Delaisi B, Corvol H, Bassinet L, Grenet D, Remus N, Vodoff MV, Boussaud V, Troussier F, Leruez-Ville M, Treluyer JM, Launay O, Sermet-Gaudelus I.
    BMC Infect Dis; 2016 Feb 01; 16():55. PubMed ID: 26830335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.